These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19249434)

  • 1. Coronary artery fistula associated with Kawasaki disease.
    Liang CD; Kuo HC; Yang KD; Wang CL; Ko SF
    Am Heart J; 2009 Mar; 157(3):584-8. PubMed ID: 19249434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
    Chen J; Liu P; Hu W; Xu Y; Deng J
    Clin Rheumatol; 2021 Oct; 40(10):4191-4197. PubMed ID: 34059986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.
    Kuo HC; Wang CL; Liang CD; Yu HR; Chen HH; Wang L; Yang KD
    J Microbiol Immunol Infect; 2007 Oct; 40(5):395-400. PubMed ID: 17932598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
    PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between maternal age and outcomes in Kawasaki disease patients.
    Huang WD; Lin YT; Tsai ZY; Chang LS; Liu SF; Lin YJ; Kuo HC
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):46. PubMed ID: 31324255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease.
    Liu R; Gao F; Huo J; Yi Q
    Platelets; 2012; 23(1):11-6. PubMed ID: 21675937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for coronary artery lesions in children with Kawasaki disease.
    Duan J; Jiang H; Lu M
    Arch Argent Pediatr; 2020 Oct; 118(5):327-331. PubMed ID: 32924395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mid- to long-term follow-up of pediatric patients with coronary artery fistula.
    Lo MH; Lin IC; Hsieh KS; Huang CF; Chien SJ; Kuo HC; Liang CD; Lin YJ
    J Formos Med Assoc; 2016 Jul; 115(7):571-6. PubMed ID: 26138373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease.
    Wei M; Huang M; Chen S; Huang G; Huang M; Qiu D; Guo Z; Jiang J; Zhou X; Yu Q; Guo Y; Fu L; Gao W; Li F
    Pediatr Cardiol; 2015 Aug; 36(6):1166-72. PubMed ID: 25812827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.
    Wang Z; Weng F; Li C; Shi H; Tang Z; Qiu H; He Y; Wu R; Chu M
    BMC Pediatr; 2018 Feb; 18(1):76. PubMed ID: 29466965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
    Weng KP; Hsieh KS; Huang SH; Ou SF; Ma CY; Ho TY; Lai CR; Ger LP
    Kaohsiung J Med Sci; 2012 Jan; 28(1):23-9. PubMed ID: 22226058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features of recurrent Kawasaki disease in 20 children].
    Zou LX; Gong FQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):617-9. PubMed ID: 18947484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of FcRs on monocytes among Kawasaki disease patients with coronary artery lesions.
    Xia Y; Tian X; Li Q; Wang G; Li C; Yang J
    Int Immunopharmacol; 2017 Apr; 45():1-5. PubMed ID: 28147297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
    Honkanen VE; McCrindle BW; Laxer RM; Feldman BM; Schneider R; Silverman ED
    Pediatr Cardiol; 2003; 24(2):122-6. PubMed ID: 12457252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease.
    Masuzawa Y; Mori M; Hara T; Inaba A; Oba MS; Yokota S
    Ther Apher Dial; 2015 Apr; 19(2):171-7. PubMed ID: 25257673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome.
    Baer AZ; Rubin LG; Shapiro CA; Sood SK; Rajan S; Shapir Y; Romano A; Bierman FZ
    Arch Pediatr Adolesc Med; 2006 Jul; 160(7):686-90. PubMed ID: 16818833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis of 942 cases of Kawasaki disease].
    Zhang W; Li Q; Zhao XD; Tang XM; Wang XG; Wang M; Wu DQ; Ou Q; Yang XQ
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):324-8. PubMed ID: 16780705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.